Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,560 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.
Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators. Saraf A, et al. Among authors: singh s, singh a. Nat Med. 2024 May;30(5):1363-1372. doi: 10.1038/s41591-024-02955-2. Epub 2024 Apr 18. Nat Med. 2024. PMID: 38637636 Free PMC article. Clinical Trial.
Augmenting the landscape of chimeric antigen receptor T-cell therapy.
Srivastava S, Singh S, Singh A. Srivastava S, et al. Among authors: singh s, singh a. Expert Rev Anticancer Ther. 2024 Aug;24(8):755-773. doi: 10.1080/14737140.2024.2372330. Epub 2024 Jun 26. Expert Rev Anticancer Ther. 2024. PMID: 38912754 Review.
Combinative workflow for mRNA vaccine development.
Khanzode R, Soni G, Srivastava S, Pawar S, Wadapurkar R, Singh A. Khanzode R, et al. Among authors: singh a. Biochem Biophys Rep. 2024 Jun 28;39:101766. doi: 10.1016/j.bbrep.2024.101766. eCollection 2024 Sep. Biochem Biophys Rep. 2024. PMID: 39040540 Free PMC article.
Neutralizing antibody responses to SARS-CoV-2 Omicron variants: Post six months following two-dose & three-dose vaccination of ChAdOx1 nCoV-19 or BBV152.
Yadav PD, Sardana V, Deshpande GR, Shinde PV, Thangaraj JWV, George LS, Sapkal GN, Patil DY, Sahay RR, Shete AM, Joshi M, Murhekar M, Godbole S, Gupta N, Prakash S, Rathore M, Ujjainiya R, Singh AP, Mishra A, Dash D, Chaudhary K, Sengupta S; ICMR Booster Dose Study Group. Yadav PD, et al. Among authors: singh ap. Indian J Med Res. 2024 Feb 1;159(2):223-231. doi: 10.4103/ijmr.ijmr_948_23. Epub 2024 Apr 4. Indian J Med Res. 2024. PMID: 38517215 Free PMC article.
25,560 results
You have reached the last available page of results. Please see the User Guide for more information.